p53 in the DNA-damage-repair process

Cold Spring Harbor Perspectives in Medicine

Volumn 6, Issue 5, 2016, Pages

  Williams, Ashley B ^a   Schumacher, Björn ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOUBLE STRANDED DNA; PROTEIN P53; RECQ HELICASE;

ARTICLE; CELL CYCLE; DNA DAMAGE; DNA END JOINING REPAIR; DNA RECOMBINATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; GENOME; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; MISMATCH REPAIR; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN FUNCTION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; NEOPLASM; PHYSIOLOGY;

ANIMALS; CELL CYCLE; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84964956080     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a026070     Document Type: Article

References (119)

1. Achanta G, Huang P. 2004. sRole of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res 64: 6233–6239.
2. Adimoolam S, Ford JM. 2002. p53 and DNA damage-inducible expression of the xeroderma pigmentosumgroup C gene. Proc Natl Acad Sci 99: 12985–12990.
3. Akyüz N, Boehden GS, Süsse S, Rimek A, Preuss U, Scheidtmann K-H, Wiesmüller L. 2002. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol Cell Biol 22: 6306–6317.
4. Arias-Lopez C, Lazaro-Trueba I, Kerr P, Lord CJ, Dexter T, Iravani M, Ashworth A, Silva A. 2006. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 7: 219–224.
5. Babbe H, McMenamin J, Hobeika E, Wang J, Rodig SJ, Reth M, Leder P. 2009.Genomic instability resulting from Blm deficiency compromises development, maintenance, and function of the B cell lineage. J Immunol 182: 347–360.
6. Bétermier M, Bertrand P, Lopez BS. 2014. Is non-homologous end-joining really an inherently error-prone process? PLoS Genet 10: e1004086.
7. Blander G, Kipnis J, Leal JF, Yu CE, Schellenberg GD, Oren M. 1999. Physical and functional interaction between p53 and the Werner’s syndrome protein. J Biol Chem 274: 29463–29469.
8. Blander G, Zalle N, Leal JF, Bar-Or RL, Yu CE, Oren M. 2000. The Werner syndrome protein contributes to induction of p53 by DNA damage. FASEB J 14: 2138–2140.
9. Boehden GS, Akyüz N, Roemer K, Wiesmüller L. 2003. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene 22: 4111–4117.
10. Boehden GS, Restle A, Marschalek R, Stocking C, Wiesmüller L. 2004. Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53. Carcinogenesis 25: 1305–1313.
11. Boehden GS, Baumann C, Siehler S, Wiesmüller L. 2005. Wild-type p53 stimulates homologous recombination upon sequence-specific binding to the ribosomal gene cluster repeat. Oncogene 24: 4183–4192.
12. Brosh RM, Karmakar P, Sommers JA, Yang Q, Wang XW, Spillare EA, Harris CC, Bohr VA. 2001. p53Modulates the exonuclease activity of Werner syndrome protein. J Biol Chem 276: 35093–35102.
13. Buck SH, Chiu D, Saito RM. 2009. The cyclin-dependent kinase inhibitors, cki-1 and cki-2, act in overlapping but distinct pathways to control cell cycle quiescence during C. elegans development. Cell Cycle 8: 2613–2620.
14. Chatterjee A, Mambo E, Osada M, Upadhyay S, Sidransky D. 2006. The effect of p53–RNAi and p53 knockout on human 8-oxoguanine DNA glycosylase (hOgg1) activity. FASEB J 20: 112–114.
15. Collister M, Lane DP, Kuehl BL. 1998. Differential expression of p53, p21waf1/cip1 and hdm2 dependent on DNA damage in Bloom’s syndrome fibroblasts. Carcinogenesis 19: 2115–2120.
16. Cranston A, Bocker T, Reitmair A, Palazzo J, Wilson T, Mak T, Fishel R. 1997. Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nat Genet 17: 114–118.
17. Croteau DL, Popuri V, Opresko PL, Bohr VA. 2014. Human RecQ helicases in DNA repair, recombination, and replication. Annu Rev Biochem 83: 519–552.
18. Cun Y, Dai N, Li M, Xiong C, Zhang Q, Sui J, Qian C, Wang D. 2014. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner. Oncol Rep 31: 901–909.
19. De S, Kumari J, Mudgal R, Modi P, Gupta S, Futami K, Goto H, Lindor NM, Furuichi Y, Mohanty D, et al. 2012. RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress. J Cell Sci 125: 2509–2522.
20. de Oliveira AHS, da Silva AE, de Oliveira IM, Henriques JAP, Agnez-Lima LF. 2014. MutY-glycosylase: An overview on mutagenesis and activities beyond the GO system. Mutat Res 769: 119–131.
21. Deriano L, Roth DB. 2013. Modernizing the nonhomologous end-joining repertoire: Alternative and classical NHEJ share the stage. Annu Rev Genet 47: 433–455.
22. Derry WB, Putzke AP, Rothman JH. 2001. Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance. Science 294: 591–595.
23. Derry WB, Bierings R, van Iersel M, Satkunendran T, Reinke V, Rothman JH. 2007. Regulation of developmental rate and germ cell proliferation in Caenorhabditis elegans by the p53 gene network. Cell Death Differ 14: 662–670.
24. Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kanaar R, Ried T, Nussenzweig A. 2002. Evidence for replicative repair ofDNAdouble-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 196: 469–480.
25. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
26. Fitch ME, Cross IV, Ford JM. 2003a. p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivo. Carcinogenesis 24: 843–850.
27. Fitch ME, Cross IV, Turner SJ, Adimoolam S, Lin CX, Williams KG, Ford JM. 2003b. The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair in p53 deficient human fibroblasts. DNA Repair 2: 819–826.
28. Fong V, Osterbur M, Capella C, Kim Y-E, Hine C, Gorbunova V, Seluanov A, Dewhurst S. 2011. Adenoviral vector driven by a minimal Rad51 promoter is selective for p53–deficient tumor cells. PLoS ONE 6: e28714.
29. Ford JM, Hanawalt PC. 1995. Li–Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in globalDNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci 92: 8876–8880.
30. Ford JM, Hanawalt PC. 1997. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J Biol Chem 272: 28073–28080.
31. Frank KM, Sharpless NE, Gao Y, Sekiguchi JM, Ferguson DO, Zhu C, Manis JP, Horner J, DePinho RA, Alt FW. 2000. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell 5: 993–1002.
32. Gaiddon C, Moorthy NC, Prives C. 1999. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 18: 5609–5621.
33. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM, Rathbun GA, Swat W, Wang J, et al. 1998. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95: 891–902.
34. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW. 2000. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897–900.
35. Garkavtsev IV, Kley N, Grigorian IA, Gudkov AV. 2001. The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control. Oncogene 20: 8276–8280.
36. Gartner A, Milstein S, Ahmed S, Hodgkin J, Hengartner MO. 2000. A conserved checkpoint pathway mediates DNA damage-induced apoptosis and cell cycle arrest in C. elegans. Mol Cell 5: 435–443.
37. Gladdy RA, Taylor MD, Williams CJ, Grandal I, Karaskova J, Squire JA, Rutka JT, Guidos CJ, Danska JS. 2003. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 3: 37–50.
38. Gong L, Gong H, Pan X, Chang C, Ou Z, Ye S, Yin L, Yang L, Tao T, Zhang Z, et al. 2015. p53 isoform Δ113p53/ Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage. Cell Res 25: 351–369.
39. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 10: 2038–2054.
40. Guirouilh-Barbat J, Lambert S, Bertrand P, Lopez BS. 2014. Is homologous recombination really an error-free process? Front Genet 5: 175.
41. Gupta S, De S, Srivastava V, Hussain M, Kumari J, Muniyappa K, Sengupta S. 2014. RECQL4 and p53 potentiate the activity of polymerase g and maintain the integrity of the human mitochondrial genome. Carcinogenesis 35: 34–45.
42. Haghighi MM, Aghagolzadeh P, Zadeh SM, Molaei M, Zali MR, Radpour R. 2014. Telomere shortening: A biological marker of sporadic colorectal cancer with normal expression of p53 and mismatch repair proteins. Genet TestMol Biomarkers 18: 236–244.
43. Hamann I, König C, Richter C, Jahnke G, Hartwig A. 2012. Impact of cadmium on hOGG1 and APE1 as a function of the cellular p53 status. Mutat Res 736: 56–63.
44. Hanson S, Kim E, Deppert W. 2005. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization. Oncogene 24: 1641–1647.
45. Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW. 2005. Characterisation of the promoter region of the humanDNA-repair gene Rad51. Eur J Gynaecol Oncol 26: 589–598.
46. Hastak K, Adimoolam S, Trinklein ND, Myers RM, Ford JM. 2012. Identification of a functional in vivo p53 response element in the coding sequence of the xeroderma pigmentosum group C gene. Genes Cancer 3: 131–140.
47. Hine CM, Li H, Xie L, Mao Z, Seluanov A, Gorbunova V. 2014. Regulation of Rad51 promoter. Cell Cycle 13: 2038–2045.
48. Hofmann ER, Milstein S, Boulton SJ, Ye M, Hofmann JJ, Stergiou L, Gartner A, Vidal M, Hengartner MO. 2002. Caenorhabditis elegans HUS-1 is a DNA damage checkpoint protein required for genome stability and EGL-1-mediated apoptosis. Curr Biol 12: 1908–1918.
49. Hwang BJ, Ford JM, Hanawalt PC, Chu G. 1999. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci 96: 424–428.
50. Jasin M, Rothstein R. 2013. Repair of strand breaks by homologous recombination. Cold Spring Harb Perspect Biol 5: a012740.
51. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11: 558–570.
52. Jeong SW, Jung HJ, Rahman MM, Hwang JN, Seo YR. 2009. Protective effects of selenomethionine against ionizing radiation under the modulation of p53 tumor suppressor. J Med Food 12: 389–393.
53. Jung HJ, Kim HL, Kim YJ, Weon J-I, Seo YR. 2013. A novel chemopreventive mechanism of selenomethionine: Enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair. Oncol Rep 30: 1581–1586.
54. Kaneko H, Fukao T, Kasahara K, Yamada T, Kondo N. 2011. Augmented cell death with Bloom syndrome helicase deficiency. Mol Med Rep 4: 607–609.
55. Lee S, Elenbaas B, Levine A, Griffith J. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013–1020.
56. Léveillard T, Andera L, Bissonnette N, Schaeffer L, Bracco L, Egly JM, Wasylyk B. 1996. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J 15: 1615–1624.
57. Lin X, Ramamurthi K, Mishima M, Kondo A, Christen RD, Howell SB. 2001. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res 61: 1508–1516.
58. Lin Y, Waldman BC, Waldman AS. 2003. Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin-a, a chemical inhibitor of p53. DNA Repair 2: 1–11.
59. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, et al. 2003. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 63: 2596–2605.
60. Liu Y, Kulesz-Martin M. 2001. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 22: 851–860.
61. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, et al. 2000. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20: 3286–3291.
62. Lu L, Harutyunyan K, Jin W, Wu J, Yang T, Chen Y, Joeng KS, Bae Y, Tao J, Dawson BC, et al. 2015. RECQL4 regulates p53 function in vivo during skeletogenesis. J Bone Miner Res 30: 1077–1089.
63. Luo Y, Lin F-T, Lin W-C. 2004. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Mol Cell Biol 24: 6430–6444.
64. Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JHJ. 2014. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol 15: 465–481.
65. Martinez P, Siegl-Cachedenier I, Flores JM, Blasco MA. 2009. MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. Aging Cell 8: 2–17.
66. Mathonnet G, Leger C, Desnoyers J, Drouin R, Therrien J-P, Drobetsky EA. 2003. UV wavelength-dependent regulation of transcription-coupled nucleotide excision repair in p53-deficient human cells. Proc Natl Acad Sci 100: 7219–7224.
67. Mirzayans R, Enns L, Dietrich K, Barley RDC, Paterson MC. 1996. Faulty DNA polymerase δ/ε-mediated excision repair in response to g radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li–Fraumeni syndrome. Carcinogenesis 17: 691–698.
68. Monnat RJ. 2010. Human RECQ helicases: Roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol 20: 329–339.
69. Mulder JE, Bondy GS, Mehta R, Massey TE. 2014. Up-regulation of nucleotide excision repair in mouse lung and liver following chronic exposure to aflatoxin B1 and its dependence on p53 genotype. Toxicol Appl Pharmacol 275: 96–103.
70. Mulder JE, Bondy GS, Mehta R, Massey TE. 2015. The impact of chronic Aflatoxin B1 exposure and p53 genotype on base excision repair in mouse lung and liver. Mutat Res 773: 63–68.
71. Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT, Jacks T. 1996. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 10: 2055–2066.
72. Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V. 1999. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 450: 197–204.
73. Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V. 2001a. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene 20: 581–589.
74. Offer H, Zurer I, Banfalvi G, Reha’k M, Falcovitz A, Milyavsky M, Goldfinger N, Rotter V. 2001b. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res 61: 88–96.
75. Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N, Rotter V. 2002. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 23: 1025–1032.
76. Oka S, Leon J, Tsuchimoto D, Sakumi K, Nakabeppu Y. 2014. MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death. Oncogenesis 3: e121.
77. Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. 2011. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem 286: 10411–10418.
78. Rieckmann T, Kriegs M, Nitsch L, Hoffer K, Rohaly G, Kocher S, Petersen C, Dikomey E, Dornreiter I, Dahm-Daphi J. 2013. p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation. Oncogene 32: 968–975.
79. Romanova LY, Willers H, Blagosklonny MV, Powell SN. 2004. The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 23: 9025–9033.
80. Rooney S, Sekiguchi J, Whitlow S, Eckersdorff M, Manis JP, Lee C, Ferguson DO, Alt FW. 2004. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci 101: 2410–2415.
81. Rubbi CP, Milner J. 2003. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J 22: 975–986.
82. 1checkpoint. Oncogene 18: 3553–3563.
83. Scherer SJ, Seib T, Seitz G, Dooley S, Welter C. 1996. Isolation and characterization of the human mismatch repair gene hMSH2 promoter region. Hum Genet 97: 114–116.
84. Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C, Schartl M. 2000. p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem 275: 37469–37473.
85. Schröer A, Köster F, Fischer D, Dubitscher RM, Woll-Hermann A, Diedrich K, Friedrich M, Salehin D. 2009. Immunohistochemistry of DNA mismatch repair enzyme MSH2 is not correlated with prognostic data from endometrial carcinomas. Anticancer Res 29: 4833–4837.
86. Schumacher B, Hofmann K, Boulton S, Gartner A. 2001. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr Biol 11: 1722–1727.
87. Schumacher B, Hanazawa M, Lee M-H, Nayak S, Volkmann K, Hofmann ER, Hofmann R, Hengartner M, Schedl T, Gartner A. 2005a. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 120: 357–368.
88. Schumacher B, Schertel C, Wittenburg N, Tuck S, Mitani S, Gartner A, Conradt B, Shaham S. 2005b. C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage. Cell Death Differ 12: 153–161.
89. Sengupta S, Harris CC. 2005. p53: Traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6: 44–55.
90. Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, Valerie K, Shay JW, Ellis NA, Wasylyk B, et al. 2003. BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J 22: 1210–1222.
91. Sengupta S, Shimamoto A, Koshiji M, Pedeux R, Rusin M, Spillare EA, Shen JC, Huang LE, Lindor NM, Furuichi Y, et al. 2005. Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 24: 1738–1748.
92. Seo YR, Fishel ML, Amundson S, Kelley MR, Smith ML. 2002a. Implication of p53 in base excision DNA repair: In vivo evidence. Oncogene 21: 731–737.
93. Seo YR, Kelley MR, Smith ML. 2002b. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci 99: 14548–14553.
94. Serrano MA, Li Z, Dangeti M, Musich PR, Patrick S, Roginskaya M, Cartwright B, Zou Y. 2013. DNA-PK, ATM and ATR collaboratively regulate p53–RPA interaction to facilitate homologous recombination DNA repair. Oncogene 32: 2452–2462.
95. Shen Y, Zhang S, Huang X, Chen K, Shen J, Wang Z. 2014. Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells. Biomed Res Int 2014: 920275.
96. Shiloh Y, Ziv Y. 2013. The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14: 197–210.
97. Sirbu BM, Lachmayer SJ, Wülfing V, Marten LM, Clarkson KE, Lee LW, Gheorghiu L, Zou L, Powell SN, Dahm-Daphi J, et al. 2011. ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells. PLoS ONE 6: e23053.
98. Smith ML, Chen IT, Zhan Q, O’Connor PM, Fornace AJ. 1995. Involvement of the p53 tumor suppressor in repair of u. v.-type DNA damage. Oncogene 10: 1053–1059.
99. Spillare EA, Robles AI, Wang XW, Shen JC, Yu CE, Schellenberg GD, Harris CC. 1999. p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev 13: 1355–1360.
100. Subramanian D, Griffith JD. 2002. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases. Nucleic Acids Res 30: 2427–2434.
101. Subramanian D, Griffith JD. 2005. Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events. Biochemistry 44: 2536–2544.
102. Sugasawa K. 2010. Regulation of damage recognition in mammalian global genomic nucleotide excision repair. Mutat Res 685: 29–37.
103. Vanasse GJ, Halbrook J, Thomas S, Burgess A, Hoekstra MF, Disteche CM, Willerford DM. 1999. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J Clin Invest 103: 1669–1675.
104. van Oers JMM, Edwards Y, Chahwan R, Zhang W, Smith C, Pechuan X, Schaetzlein S, Jin B, Wang Y, Bergman A, et al. 2014. The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair. Oncogene 33: 3939–3946.
105. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG. 1995. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 10: 188–195.
106. Wang XW, Tseng A, Ellis NA, Spillare EA, Linke SP, Robles AI, Seker H, Yang Q, Hu P, Beresten S, et al. 2001. Functional interaction of p53 and BLM DNA helicase in apoptosis. J Biol Chem 276: 32948–32955.
107. Wani MA, Zhu Q, El-Mahdy M, Venkatachalam S, Wani AA. 2000. Enhanced sensitivity to anti-benzo(a)pyrene-diolepoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Res 60: 2273–2280.
108. Wani MA, El-Mahdy MA, Hamada FM, Wani G, Zhu Q, Wang Q-E, Wani AA. 2002. Efficient repair of bulky anti-BPDE DNA adducts from non-transcribed DNA strand requires functional p53 but not p21(waf1/cip1) and pRb. Mutat Res 505: 13–25.
109. 1/S cell cycle checkpoint control. Oncogene 19: 632–639.
110. Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BHF, et al. 2006. Interaction of Werner and Bloom syndrome geneswith p53 in familial breast cancer. Carcinogenesis 27: 1655–1660.
111. Yang Q, Zhang R, Wang XW, Spillare EA, Linke SP, Subramanian D, Griffith JD, Li JL, Hickson ID, Shen JC, et al. 2002. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J Biol Chem 277: 31980–31987.
112. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937–948.
113. Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, Mitra S, Bhakat KK. 2008. Regulation of the human A Pendonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res 36: 1555–1566.
114. Zhang X, Zhu Y, Geng L, Wang H, Legerski RJ. 2009. Artemis is a negative regulator of p53 in response to oxidative stress. Oncogene 28: 2196–2204.
115. Zhou J, Prives C. 2003. Replication of damaged DNA in vitro is blocked by p53. Nucleic Acids Res 31: 3881–3892.
116. Zhou J, Ahn J, Wilson SH, Prives C. 2001. A role for p53 in base excision repair. EMBO J 20: 914–923.
117. Zhu Q, Wani MA, El-Mahdy M, Wani AA. 2000. Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand. J Biol Chem 275: 11492–11497.
118. Zink D, Mayr C, Janz C, Wiesmüller L. 2002. Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene 21: 4788–4800.
119. Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC, Rotter V. 2004. The role of p53 in base excision repair following genotoxic stress. Carcinogenesis 25: 11–19.